These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9573223)

  • 1. Combinatorial blockade of calcineurin and CD28 signaling facilitates primary and secondary therapeutic gene transfer by adenovirus vectors in dystrophic (mdx) mouse muscles.
    Guibinga GH; Lochmuller H; Massie B; Nalbantoglu J; Karpati G; Petrof BJ
    J Virol; 1998 Jun; 72(6):4601-9. PubMed ID: 9573223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice.
    Lochmüller H; Petrof BJ; Pari G; Larochelle N; Dodelet V; Wang Q; Allen C; Prescott S; Massie B; Nalbantoglu J; Karpati G
    Gene Ther; 1996 Aug; 3(8):706-16. PubMed ID: 8854096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficiency and functional consequences of adenovirus-mediated in vivo gene transfer to normal and dystrophic (mdx) mouse diaphragm.
    Petrof BJ; Acsadi G; Jani A; Massie B; Bourdon J; Matusiewicz N; Yang L; Lochmüller H; Karpati G
    Am J Respir Cell Mol Biol; 1995 Nov; 13(5):508-17. PubMed ID: 7576685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Starling forces and muscle fiber maturity permits adenovirus-mediated gene transfer to adult dystrophic (mdx) mice by the intravascular route.
    Cho WK; Ebihara S; Nalbantoglu J; Gilbert R; Massie B; Holland P; Karpati G; Petrof BJ
    Hum Gene Ther; 2000 Mar; 11(5):701-14. PubMed ID: 10757350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (MDX) mice.
    Yang L; Lochmuller H; Luo J; Massie B; Nalbantoglu J; Karpati G; Petrof BJ
    Gene Ther; 1998 Mar; 5(3):369-79. PubMed ID: 9614557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory muscles as a target for adenovirus-mediated gene therapy.
    Petrof BJ
    Eur Respir J; 1998 Feb; 11(2):492-7. PubMed ID: 9551759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
    Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
    Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of force generation after adenovirus-mediated gene transfer to muscle is alleviated by adenoviral gene inactivation and host CD8+ T cell deficiency.
    Petrof BJ; Lochmüller H; Massie B; Yang L; Macmillan C; Zhao JE; Nalbantoglu J; Karpati G
    Hum Gene Ther; 1996 Oct; 7(15):1813-26. PubMed ID: 8894673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product.
    Yuasa K; Sakamoto M; Miyagoe-Suzuki Y; Tanouchi A; Yamamoto H; Li J; Chamberlain JS; Xiao X; Takeda S
    Gene Ther; 2002 Dec; 9(23):1576-88. PubMed ID: 12424610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained muscle expression of dystrophin from a high-capacity adenoviral vector with systemic gene transfer of T cell costimulatory blockade.
    Jiang Z; Schiedner G; van Rooijen N; Liu CC; Kochanek S; Clemens PR
    Mol Ther; 2004 Oct; 10(4):688-96. PubMed ID: 15451453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTLA4Ig delivered by high-capacity adenoviral vector induces stable expression of dystrophin in mdx mouse muscle.
    Jiang Z; Schiedner G; Gilchrist SC; Kochanek S; Clemens PR
    Gene Ther; 2004 Oct; 11(19):1453-61. PubMed ID: 15269713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles.
    Floyd SS; Clemens PR; Ontell MR; Kochanek S; Day CS; Yang J; Hauschka SD; Balkir L; Morgan J; Moreland MS; Feero GW; Epperly M; Huard J
    Gene Ther; 1998 Jan; 5(1):19-30. PubMed ID: 9536261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscle of dystrophic dogs: prolongation of expression with immunosuppression.
    Howell JM; Lochmüller H; O'Hara A; Fletcher S; Kakulas BA; Massie B; Nalbantoglu J; Karpati G
    Hum Gene Ther; 1998 Mar; 9(5):629-34. PubMed ID: 9551611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes simplex virus VP22 enhances adenovirus-mediated microdystrophin gene transfer to skeletal muscles in dystrophin-deficient (mdx) mice.
    Xiong F; Xiao S; Peng F; Zheng H; Yu M; Ruan Y; Li W; Shang Y; Zhao C; Zhou W; Chen H; Chamberlain JS; Fang L; Zhang C
    Hum Gene Ther; 2007 Jun; 18(6):490-501. PubMed ID: 17550336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer.
    Cerletti M; Negri T; Cozzi F; Colpo R; Andreetta F; Croci D; Davies KE; Cornelio F; Pozza O; Karpati G; Gilbert R; Mora M
    Gene Ther; 2003 May; 10(9):750-7. PubMed ID: 12704413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic gene transfer to dystrophic diaphragm by an adenoviral vector deleted of all viral genes.
    Matecki S; Dudley RW; Divangahi M; Gilbert R; Nalbantoglu J; Karpati G; Petrof BJ
    Am J Physiol Lung Cell Mol Physiol; 2004 Sep; 287(3):L569-76. PubMed ID: 15155269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products.
    Yuasa K; Yoshimura M; Urasawa N; Ohshima S; Howell JM; Nakamura A; Hijikata T; Miyagoe-Suzuki Y; Takeda S
    Gene Ther; 2007 Sep; 14(17):1249-60. PubMed ID: 17581597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene.
    Deconinck N; Ragot T; Maréchal G; Perricaudet M; Gillis JM
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3570-4. PubMed ID: 8622977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forced myofiber regeneration promotes dystrophin gene transfer and improved muscle function despite advanced disease in old dystrophic mice.
    Guibinga GH; Ebihara S; Nalbantoglu J; Holland P; Karpati G; Petrof BJ
    Mol Ther; 2001 Nov; 4(5):499-507. PubMed ID: 11708887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved adenoviral vectors for gene therapy of Duchenne muscular dystrophy.
    Hauser MA; Amalfitano A; Kumar-Singh R; Hauschka SD; Chamberlain JS
    Neuromuscul Disord; 1997 Jul; 7(5):277-83. PubMed ID: 9267841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.